Aug 12, 2020
New Recommendations Aim to Increase Capacity for Specialized Care for Adults Living with Sickle Cell Disease
Apr 13, 2020
SCD takes part in an Israeli initiative led by the IMOD and IDF in an emergency-mode effort to fight the COVID-19 Virus
Nov 25, 2019
California to Expand Innovative Adult Sickle Cell Disease Clinics Statewide
Nov 14, 2019
Sickle Cell Disease (SCD) Epidemiology Forecast to 2028: Focus on Turkey, Saudi Arabia, UAE, Mexico, Colombia, Brazil, and Argentina
Oct 07, 2019
AUSA 2019: SCD Continues its Growth, Announcing Additional Contracts Valued at More than USD 15M for SWIR Solutions
Sep 25, 2019
SCD Wins Numerous Programs for its HOT Low SWaP-C Mid-Wave Infra-Red (MWIR) Products Totaling $20M and Ramps Up the New Generation Sparrow Video Core
Nov 15, 2018
ASH Establishes ASH Research Collaborative to Accelerate Progress in Hematology
Sep 12, 2018
American Society of Hematology to Launch Sickle Cell Disease Clinical Trials Network
Jul 13, 2018
Modus Therapeutics Completes a SEK 140 Million Financing led by HealthCap
Jun 11, 2018
MaxCyte and U.S. National Institutes of Health's National Heart, Lung, and Blood Institute Enter Cooperative Research & Development Agreement for Sickle Cell Disease
Sep 28, 2017
Sickle Cell Disease Forecast in 10 Major Markets 2017-2027 - USA, France, Germany, Italy, Spain, UK, Brazil, Russia, Canada and India
Sep 19, 2017
Sancilio Pharmaceuticals Company, Inc. (SPCI) Receives Rare Pediatric Disease Designation From the US Food and Drug Administration for Altemia a Treatment of Sickle Cell Disease (SCD) in Children